Dr. Okunola's latest newsletter dives into the latest Covid-19 data from the CDC. While Covid-19 is now the 10th leading cause of death, it it still more severe than the flue.
This research conducted interviews via telemedicine of 165 patients with Long COVID over a 2-year time frame.
This research conducted interviews via telemedicine of 165 patients with Long COVID over a 2-year time frame.
Researchers are looking at whether medications used to treat or prevent HIV may also alleviate long Covid symptoms.
Chimére L Sweeney emphasizes the need for awareness, stating, "I want to help Black people tell their stories of long covid." The discussion highlights the importance of empathy and support for those affected, advocating for better healthcare access and understanding.
Danielle Beckham Neuroscientist at the @CNPRCresearch . MS in Biophysics, PhD in Biological Chemistry. With her latest entry to NeuroArt "Unwelcome guest: SARS-Cov-2" - If you like it, please vote!
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t
A study on long Covid patients revealed persistent immune activation and potential virus presence in various organs even years after infection. The research utilized imaging techniques to identify immune activation in the brain, spinal cord, lungs, and gut wall. The findings suggest a need for further investigation into treatments targeting leftover virus and immunomodulating therapies....
with further research existing treatments targeting the eradication/reduction of these type of autoantibodies for Long COVID could be used and biomarkers (blood tests to show the presence of Long COVID) could be developed to identify these autoantibodies in Long Haulers who have these types of neurological symptoms, particularly those with chronic pain.